3 terminated, 2 completed, 2 unknown, 1 recruiting. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Terminated 3, Completed 2, Unknown 2, Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Neuroma: new trials by email Literature Review of Neuroma trials Research Report on Neuroma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients Steroids therapy, Placebo - Vestibular Schwannoma, Facial Nerve Paralysis | Phase 3 | Recruiting | Beijing Tiantan Hospital | 364 | 2025-10-09 | 2026-10-26 |
| Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas REC-2282, Placebo - Neurofibromatosis Type 2 | Phase 2 / Phase 3 | Terminated | Recursion Pharmaceuticals Inc. | 25 | 2022-06-20 | 2026-08-17 |
| Vitamin D3 in Sensory Recovery After Digital NERVe Suture (D3NERV). Cholecalciferol, Placebos - Digital Nerve Injury | Phase 3 | Unknown | University Hospital, Caen | 72 | 2020-01-20 | 2021-08-31 |
| Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections Brolucizumab, Aflibercept - Age-Related Macular Degeneration | Phase 3 | Terminated | Novartis Pharmaceuticals | 535 | 2018-10-30 | 2023-01-30 |
| Stereotactic Radiation in Vestibular Schwannoma stereotactic radiotherapy, stereotactic radiosurgery - Vestibular Schwannoma | Phase 3 | Unknown | Ramathibodi Hospital | 200 | 2011-10-01 | 2011-10-10 |
| Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain Ralfinamide - Pain | Phase 3 | Completed | Newron Pharmaceuticals SPA | 411 | 2009-03-20 | 2017-09-15 |
| Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery methylprednisolone - Facial Palsy | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 313 | 2007-03-01 | 2012-07-10 |
| Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome lidocaine patch 5% - Carpal Tunnel Syndrome | Phase 3 | Terminated | Endo USA Inc., a Keenova Therapeutics Company | 210 | 2005-11-01 | 2011-06-14 |
Neuroma, Acoustic (3) · Facial Paralysis (2) · Neurofibromatosis 2 (2) · Pain (2) · Bell Palsy (1) · Carpal Tunnel Syndrome (1) · Macular Degeneration (1)
Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms, Nerve Tissue (8) · Nerve Sheath Neoplasms (8) · Nervous System Diseases (6) · Cranial Nerve Diseases (5) · Cranial Nerve Neoplasms (5) · Ear Diseases (5) · Neoplasms, Germ Cell and Embryonal (5) · Neurilemmoma (5) · Neuroectodermal Tumors (5) · Neuroendocrine Tumors (5) · Otorhinolaryngologic Diseases (5) · Otorhinolaryngologic Neoplasms (5)
Cholecalciferol (1) · HDAC-42 (1) · Lidoderm (1) · Methylprednisolone (1) · Radiosurgery (1) · Ralfinamide (1) · aflibercept (1) · brolucizumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Beijing Tiantan Hospital (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Newron Pharmaceuticals SPA (1) · Novartis Pharmaceuticals (1) · Ramathibodi Hospital (1) · Recursion Pharmaceuticals Inc. (1) · University Hospital, Caen (1)
United States (3) · France (2) · United Kingdom (2) · China (1) · Puerto Rico (1)
Putipun Puataweepong, M.D. (1) · Stefano Rossetti, MD (1)
2018 (1)